End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
38.6
CNY
|
-0.97%
|
|
-3.02%
|
+33.15%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
18,279
|
18,131
|
14,706
|
13,164
|
14,937
|
19,743
|
-
|
-
|
Enterprise Value (EV)
1 |
10,850
|
15,079
|
12,430
|
9,339
|
12,067
|
22,223
|
23,094
|
19,743
|
P/E ratio
|
15.3
x
|
14
x
|
11.9
x
|
9.48
x
|
10.1
x
|
12.2
x
|
11.4
x
|
10.3
x
|
Yield
|
0.88%
|
1.75%
|
1.62%
|
2.43%
|
2.35%
|
1.97%
|
2.13%
|
2.2%
|
Capitalization / Revenue
|
0.35
x
|
0.3
x
|
0.22
x
|
0.18
x
|
0.2
x
|
0.25
x
|
0.23
x
|
0.22
x
|
EV / Revenue
|
0.21
x
|
0.25
x
|
0.18
x
|
0.13
x
|
0.16
x
|
0.28
x
|
0.27
x
|
0.22
x
|
EV / EBITDA
|
4.14
x
|
6.05
x
|
5.29
x
|
3.42
x
|
4.18
x
|
7.31
x
|
6.99
x
|
5.69
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.52
x
|
1.41
x
|
1.06
x
|
0.87
x
|
0.93
x
|
1.14
x
|
1.08
x
|
1
x
|
Nbr of stocks (in thousands)
|
556,565
|
556,565
|
556,565
|
556,565
|
556,565
|
556,565
|
-
|
-
|
Reference price
2 |
34.89
|
35.23
|
28.45
|
25.30
|
28.99
|
38.60
|
38.60
|
38.60
|
Announcement Date
|
3/24/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
52,046
|
59,649
|
68,358
|
73,443
|
75,477
|
80,346
|
85,878
|
90,328
|
EBITDA
1 |
2,619
|
2,490
|
2,349
|
2,731
|
2,885
|
3,040
|
3,306
|
3,470
|
EBIT
1 |
1,720
|
2,164
|
1,952
|
2,306
|
2,467
|
2,820
|
2,880
|
3,146
|
Operating Margin
|
3.3%
|
3.63%
|
2.86%
|
3.14%
|
3.27%
|
3.51%
|
3.35%
|
3.48%
|
Earnings before Tax (EBT)
1 |
1,857
|
2,157
|
1,975
|
2,311
|
2,473
|
2,780
|
2,912
|
3,188
|
Net income
1 |
1,271
|
1,402
|
1,336
|
1,487
|
1,599
|
1,766
|
1,892
|
2,087
|
Net margin
|
2.44%
|
2.35%
|
1.96%
|
2.02%
|
2.12%
|
2.2%
|
2.2%
|
2.31%
|
EPS
2 |
2.285
|
2.515
|
2.400
|
2.669
|
2.870
|
3.175
|
3.401
|
3.750
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3077
|
0.6154
|
0.4615
|
0.6154
|
0.6800
|
0.7600
|
0.8238
|
0.8500
|
Announcement Date
|
3/24/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
18,148
|
17,151
|
18,978
|
18,488
|
18,826
|
18,687
|
19,701
|
18,198
|
18,892
|
19,090
|
20,938
|
19,341
|
20,078
|
20,992
|
22,131
|
EBITDA
|
520.2
|
448.4
|
687.7
|
599.2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
359.3
|
375.1
|
657.3
|
531.9
|
741.8
|
576.4
|
718.8
|
527.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
1.98%
|
2.19%
|
3.46%
|
2.88%
|
3.94%
|
3.08%
|
3.65%
|
2.9%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
375.1
|
376.8
|
657.8
|
534.8
|
741.7
|
578.5
|
713.2
|
528.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
262.3
|
252.4
|
421.9
|
373.4
|
439.1
|
362.2
|
468
|
359.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
1.45%
|
1.47%
|
2.22%
|
2.02%
|
2.33%
|
1.94%
|
2.38%
|
1.97%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.4692
|
0.4538
|
0.7538
|
0.6769
|
0.7846
|
0.6538
|
0.8362
|
0.6500
|
0.7300
|
0.7000
|
0.8000
|
0.7900
|
0.7200
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/15/22
|
4/19/22
|
8/30/22
|
10/24/22
|
3/15/23
|
4/17/23
|
8/28/23
|
10/26/23
|
3/15/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
2,481
|
3,352
|
-
|
Net Cash position
1 |
7,429
|
3,051
|
2,276
|
3,825
|
2,870
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
0.8162
x
|
1.014
x
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
10.4%
|
10.5%
|
9.29%
|
9.59%
|
9.56%
|
9.67%
|
9.63%
|
9.63%
|
ROA (Net income/ Total Assets)
|
4.07%
|
3.83%
|
3.24%
|
3.48%
|
-
|
3.53%
|
3.67%
|
3.8%
|
Assets
1 |
31,225
|
36,557
|
41,189
|
42,699
|
-
|
49,995
|
51,609
|
54,921
|
Book Value Per Share
2 |
23.00
|
25.10
|
26.80
|
29.00
|
31.30
|
33.80
|
35.80
|
38.70
|
Cash Flow per Share
2 |
3.590
|
2.700
|
2.970
|
4.600
|
5.280
|
5.610
|
3.640
|
3.870
|
Capex
1 |
245
|
285
|
369
|
322
|
284
|
402
|
404
|
373
|
Capex / Sales
|
0.47%
|
0.48%
|
0.54%
|
0.44%
|
0.38%
|
0.5%
|
0.47%
|
0.41%
|
Announcement Date
|
3/24/20
|
3/15/21
|
3/15/22
|
3/15/23
|
3/15/24
|
-
|
-
|
-
|
Last Close Price
38.6
CNY Average target price
38.77
CNY Spread / Average Target +0.45% Consensus |
1st Jan change
|
Capi.
|
---|
| +33.15% | 2.76B | | +20.23% | 73.31B | | -4.43% | 23.98B | | +4.89% | 8.8B | | +9.21% | 8.6B | | -20.79% | 8.07B | | -1.41% | 4.16B | | +12.27% | 4.14B | | -2.75% | 3.88B | | +23.24% | 3.72B |
Pharmaceuticals Wholesale
|